Home / I.V. Therapy / I.V. Therapy Accessories / Disinfecting Cap / Disinfecting Cap 3M™ Curos Jet™CSA1-270
Picture of Disinfecting Cap 3M™ Curos Jet™CSA1-270

Disinfecting Cap 3M™ Curos Jet™CSA1-270

Disinfecting-Cap-3M™-Curos-Jet™CSA1-270

SKU #

#1053652

MPN #

CSA1-270

Brand

3M

Stock

In Stock

Quantity

100

Features

CAP, DISINF CUROS OPN FML LUERRED (270/BX 8BX/CS)

$708.03 USD

Product Specifications Product Usage Additional Information
Print
Attribute Name Attribute Value
McKesson # 1053652
Manufacturer # CSA1-270
Brand 3M™ Curos Jet™
Manufacturer 3M
Application Disinfecting Cap
For Use With For Open Female Luers CSA1-270
Specifications Red, Single Use, 70% isopropyl alcohol (IPA)
UNSPSC Code 42221610
Compare Selected Items Email

Similar Items

Underarm Crutches McKesson Aluminum Frame Tall Adult 350 lbs. Weight Capacity Push Button - Adjustment

One Size Fits Most White NonSterile Not Rated 8211

In Stock

PR/1 $9.76 USD

Underarm Crutches McKesson Aluminum Frame Tall Adult 350 lbs. Weight Capacity Push Button - Adjustment

One Size Fits Most White NonSterile Not Rated 8211

In Stock

PR/1 $9.76 USD

Underarm Crutches McKesson Aluminum Frame Tall Adult 350 lbs. Weight Capacity Push Button - Adjustment

One Size Fits Most White NonSterile Not Rated 8211

In Stock

PR/1 $9.76 USD

Underarm Crutches McKesson Aluminum Frame Tall Adult 350 lbs. Weight Capacity Push Button - Adjustment

One Size Fits Most White NonSterile Not Rated 8211

In Stock

PR/1 $9.76 USD

  • Disinfects in 1 minute. Protects ports for up to 7 days if not removed.
  • Designed to luer lock onto a wide range of stopcocks and catheter hubs.
  • Unique cap design holds pressure to maintain a closed system.
  • Brightly colored to help clinicians verify and measure compliance.
  • In vitro testing shows effectiveness against six microorganisms commonly associated with CLABSI: Staphylococcus aureus, Staphylococcus epidermidis, Escherichia coli, Pseudomonas aeruginosa, Candida glabrata, and Candida albicans.
  • Addresses stopcock comtamination concerns highlighted in the 2016 Infusion Therapy Standards of Practice published by INS.